Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-13

FDA Approved: TOBRADEX ST — Original Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved TOBRADEX ST (tobramycin/dexamethasone) from Harrow Eye, LLC via an original NDA for treating ocular infections and inflammatory conditions due …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRADEX ST (TOBRAMYCIN / DEXAMETHASONE)

Snippet

ORIG AP for TOBRADEX ST (TOBRAMYCIN / DEXAMETHASONE)